Sienna Biopharmaceuticals, Inc.
SNNAQ · OTC
9/30/2019 | 6/30/2019 | 3/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Market Cap | $6,145 | $26,924 | $58,316 | $48,268 |
| - Cash | $11,332 | $49,207 | $57,169 | $48,526 |
| + Debt | $0 | $30,018 | $29,824 | $30,125 |
| Enterprise Value | -$5,187 | $7,735 | $30,971 | $29,867 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$8,805 | -$7,690 | -$15,800 | -$19,729 |
| % Margin | – | – | – | – |
| Net Income | -$3,970 | -$8,264 | -$16,382 | -$19,295 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.13 | -0.27 | -0.67 | -0.93 |
| % Growth | 51.9% | 59.7% | 28% | – |
| Operating Cash Flow | -$17,844 | -$8,417 | -$12,769 | -$15,599 |
| Capital Expenditures | $0 | $0 | -$4 | -$6 |
| Free Cash Flow | -$17,844 | -$8,417 | -$12,773 | -$15,605 |